Jiangsu Apon Medical Technology Co Ltd Class A (300753.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · China · ISIN CNE100003FV4
Jiangsu Apon Medical Technology Co Ltd Class A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 403.80 m CNY | 342.02 m CNY |
| Gross profit | 276.06 m CNY | 234.07 m CNY |
| Operating income | 23.49 m CNY | -25.89 m CNY |
| EBIT | 24.63 m CNY | -22.83 m CNY |
| Net income | 10.80 m CNY | -24.02 m CNY |
| Diluted EPS – continuing operations | 0.09 CNY | -0.19 CNY |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Jiangsu Apon Medical Technology Co Ltd Class A
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices for anesthesia and analgesia, nasal airway, and chronic pain management in China. It offers pain management services, such as high-precision intelligent microcomputer infusion pumps, wireless analgesia management systems, internal heat needle therapy devices, low-frequency therapy devices, and shockwave therapy devices; and iPainfree, a wireless analgesia management system software. The company also provides nasal and upper airway management solutions, including daily nasal care, perioperative care for nasal diseases, rhinitis diagnosis and treatment, snoring diagnosis and treatment, and allergy treatment; and sleep monitoring and improvement solutions. In addition, it is involved in research and development of digital diagnostic and treatment products for neurological diseases, cognitive training, and sleep monitoring; and research, development, production, and sale of medical devices comprising brain neuromodulation and intracranial implantable electrodes. Jiangsu Apon Medical Technology Co., Ltd. was founded in 2001 and is headquartered in Nantong, China.
More stocks
- Citra Putra Realty Tbk PT (CLAY.JK)
- Cham Swiss Properties AG (CHAM.SW)
- BrightSpire Capital, Inc. (BRSP)
- Changzhou Evergreen Technology Co. Ltd. A (001324.SZ)
- Onconic Therapeutics Inc. (476060.KQ)
- IQE PLC (IQE.L)
- Xinjiang Chalkis Co Ltd (000972.SZ)
- First Bancorp, Inc /ME/ (FNLC)
- CHEMUNG FINANCIAL CORP (CHMG)
- CITIZENS FINANCIAL SERVICES INC (CZFS)
- Surya Permata Andalan Tbk PT (NATO.JK)
- Hyundai Bioscience Co. Ltd (048410.KQ)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.